We are excited to share our latest development status. Similar to its position in the United States, we are pleased to announce that Afatinib, which is being treated with DFP-14323 in our ongoing ...
In observance of Lung Cancer Awareness Month this November, Metropolis Healthcare, one of India's leading and most reputed diagnostic chains, conducted a landmark seven-year research study (2015-2021) ...